首页 > 最新文献

International Journal of Preventive Medicine最新文献

英文 中文
The Role of Vitamins and Minerals Supplementation on COVID-19 Prevention: Benefit or Risk? 维生素和矿物质补充剂在预防新冠肺炎中的作用:益处还是风险?
IF 2.1 Pub Date : 2023-06-22 eCollection Date: 2023-01-01 DOI: 10.4103/ijpvm.ijpvm_138_21
Erika Aparecida Silveira, Patricia Constante Jaime, Matias Noll, Cesar de Oliveira
{"title":"The Role of Vitamins and Minerals Supplementation on COVID-19 Prevention: Benefit or Risk?","authors":"Erika Aparecida Silveira, Patricia Constante Jaime, Matias Noll, Cesar de Oliveira","doi":"10.4103/ijpvm.ijpvm_138_21","DOIUrl":"https://doi.org/10.4103/ijpvm.ijpvm_138_21","url":null,"abstract":"","PeriodicalId":14342,"journal":{"name":"International Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6a/05/IJPVM-14-84.PMC10580208.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49677391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychometric Properties of the Persian Version of Cystic Fibrosis Questionnaire: Revised in Children with Cystic Fibrosis. 波斯版囊性纤维化问卷的心理测量特性:在囊性纤维化儿童中修订。
IF 2.1 Pub Date : 2023-06-22 eCollection Date: 2023-01-01 DOI: 10.4103/ijpvm.ijpvm_137_22
Naser Havaei, Mohammad Reza Modaresi, Mandana Rezaei, Mohammad Asghari-Jafarabadi, Ameneh Kohzadi, Yalda Ariafar, Babak Ghalibaf, Sakineh Goljaryan

Background: Cystic fibrosis is a progressive, fatal disease affecting the quality of life. The cystic fibrosis questionnaire-revised (CFQ-R) is an efficient tool to monitor health-related quality of life in patients. The aim of this study was to explore the psychometric properties of the child and parent versions of the Persian version of the CFQ-R in the Iranian population.

Methods: Fifty children with cystic fibrosis (6-11 years) and their parents were allocated in this methodological study to examine convergent validity, discriminant validity, test-retest reliability (n = 30), internal consistency, ceiling and floor effects, and agreement between two versions of the CFQ-R.

Results: Convergent validity was confirmed for parent proxy (P < 0.05). CFQ-R discriminated patients among stages of disease severity based on lung function, age, and BMI (P < 0.05). Test-retest analysis revealed good to excellent reliability (inter-class correlation coefficient (ICC) = 0.78-0.97). In most domains, lower quality of life scores was obtained in the parent proxy compared to the child version (P < 0.05). Domain-specific correlations were found between the child version and parent proxy (P < 0.05). Internal consistency was generally confirmed (α = 0.13-0.83 in child version and α = 0.25-0.87 in parent proxy). There were no floor effects. Ceiling effects were mostly seen for physical, digestion, and body image domains in the child version and for eating, weight, and school domains in the parent proxy.

Conclusions: The child version and parent proxy of the Persian CFQ-R are valid and reliable measures and can be applied in clinical trials to monitor the quality of life in children with cystic fibrosis. It is recommended to use both versions in conjunction to better interpret the quality of life aspects of children with cystic fibrosis.

背景:囊性纤维化是一种影响生活质量的进行性致命疾病。囊性纤维化调查表修订版(CFQ-R)是监测患者健康相关生活质量的有效工具。本研究的目的是探索伊朗人群中波斯版CFQ-R的儿童和父母版本的心理测量特性。方法:50名囊性纤维化儿童(6-11岁)及其父母被分配到本方法学研究中,以检验收敛有效性、判别有效性、重测信度(n=30)、内部一致性、上限和下限效应,以及两个版本的CFQ-R之间的一致性。结果:父母代理的收敛有效性得到证实(P<0.05)。CFQ-R根据肺功能、年龄和BMI在疾病严重程度的不同阶段区分患者(P<0.05),与儿童版相比,父母版的生活质量得分较低(P<0.05)。儿童版和父母版之间存在领域特异性相关性(P<0.05),内部一致性得到了普遍证实(儿童版α=0.13-0.83,父母版α=0.25-0.87)。没有地板效应。在儿童版中,上限效应主要出现在身体、消化和身体形象领域,在父母代理中,上限影响主要出现在饮食、体重和学校领域。结论:儿童版和父母代波斯CFQ-R是有效可靠的测量方法,可用于监测囊性纤维化儿童生活质量的临床试验。建议将这两个版本结合使用,以更好地解释囊性纤维化儿童的生活质量。
{"title":"Psychometric Properties of the Persian Version of Cystic Fibrosis Questionnaire: Revised in Children with Cystic Fibrosis.","authors":"Naser Havaei,&nbsp;Mohammad Reza Modaresi,&nbsp;Mandana Rezaei,&nbsp;Mohammad Asghari-Jafarabadi,&nbsp;Ameneh Kohzadi,&nbsp;Yalda Ariafar,&nbsp;Babak Ghalibaf,&nbsp;Sakineh Goljaryan","doi":"10.4103/ijpvm.ijpvm_137_22","DOIUrl":"https://doi.org/10.4103/ijpvm.ijpvm_137_22","url":null,"abstract":"<p><strong>Background: </strong>Cystic fibrosis is a progressive, fatal disease affecting the quality of life. The cystic fibrosis questionnaire-revised (CFQ-R) is an efficient tool to monitor health-related quality of life in patients. The aim of this study was to explore the psychometric properties of the child and parent versions of the Persian version of the CFQ-R in the Iranian population.</p><p><strong>Methods: </strong>Fifty children with cystic fibrosis (6-11 years) and their parents were allocated in this methodological study to examine convergent validity, discriminant validity, test-retest reliability (<i>n</i> = 30), internal consistency, ceiling and floor effects, and agreement between two versions of the CFQ-R.</p><p><strong>Results: </strong>Convergent validity was confirmed for parent proxy (<i>P</i> < 0.05). CFQ-R discriminated patients among stages of disease severity based on lung function, age, and BMI (<i>P</i> < 0.05). Test-retest analysis revealed good to excellent reliability (inter-class correlation coefficient (ICC) = 0.78-0.97). In most domains, lower quality of life scores was obtained in the parent proxy compared to the child version (<i>P</i> < 0.05). Domain-specific correlations were found between the child version and parent proxy (<i>P</i> < 0.05). Internal consistency was generally confirmed (α = 0.13-0.83 in child version and α = 0.25-0.87 in parent proxy). There were no floor effects. Ceiling effects were mostly seen for physical, digestion, and body image domains in the child version and for eating, weight, and school domains in the parent proxy.</p><p><strong>Conclusions: </strong>The child version and parent proxy of the Persian CFQ-R are valid and reliable measures and can be applied in clinical trials to monitor the quality of life in children with cystic fibrosis. It is recommended to use both versions in conjunction to better interpret the quality of life aspects of children with cystic fibrosis.</p>","PeriodicalId":14342,"journal":{"name":"International Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/33/34/IJPVM-14-83.PMC10580193.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49677380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Prevalence of Inflammatory Bowel Disease (IBD) in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis. 多发性硬化症(MS)患者炎症性肠病(IBD)的患病率:系统综述和荟萃分析。
IF 2.1 Pub Date : 2023-06-22 eCollection Date: 2023-01-01 DOI: 10.4103/ijpvm.ijpvm_44_22
Amirreza Nasirzadeh, Reza Jahanshahi, Mahsa Ghajarzadeh, Aida Mohammadi, Abdorreza Naser Moghadasi

Background: This systematic review and meta-analysis aim to update the pooled prevalence of Inflammatory bowel disease (IBD) in patients with multiple sclerosis (MS).

Methods: Two researchers independently and systematically searched PubMed, Scopus, EMBASE, Web of Science, and google scholar. They also searched for references of the included studies, and conference abstracts that were published up to September 2021.

Results: The literature search revealed 5719 articles, after deleting duplicates 3616 remained. Finally, 17 studies were included. The pooled prevalence of IBD in MS was 1% (I2 = 96.3%, P < 0.001). The pooled odds ratio of developing IBD in MS cases was 1.36 (95% CI: 1.1-1.6) (I2 = 58.3, P = 0.01).

Conclusions: The results of this systematic review and meta-analysis show that the pooled prevalence of IBD in MS patients was 1% and the pooled odds ratio of developing IBD in MS cases was 1.36.

背景:本系统综述和荟萃分析旨在更新多发性硬化症(MS)患者炎症性肠病(IBD)的合并患病率。方法:两名研究人员独立系统地搜索PubMed、Scopus、EMBASE、Web of Science和谷歌学者。他们还搜索了截至2021年9月发表的纳入研究的参考文献和会议摘要。结果:文献搜索显示了5719篇文章,删除了重复的3616篇。最后,纳入了17项研究。多发性硬化症合并IBD的患病率为1%(I2=96.3%,P<0.001)。多发性痴呆症合并发生IBD的比值比为1.36(95%CI:1.1-1.6)(I2=58.3,P=0.01)。
{"title":"The Prevalence of Inflammatory Bowel Disease (IBD) in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis.","authors":"Amirreza Nasirzadeh,&nbsp;Reza Jahanshahi,&nbsp;Mahsa Ghajarzadeh,&nbsp;Aida Mohammadi,&nbsp;Abdorreza Naser Moghadasi","doi":"10.4103/ijpvm.ijpvm_44_22","DOIUrl":"https://doi.org/10.4103/ijpvm.ijpvm_44_22","url":null,"abstract":"<p><strong>Background: </strong>This systematic review and meta-analysis aim to update the pooled prevalence of Inflammatory bowel disease (IBD) in patients with multiple sclerosis (MS).</p><p><strong>Methods: </strong>Two researchers independently and systematically searched PubMed, Scopus, EMBASE, Web of Science, and google scholar. They also searched for references of the included studies, and conference abstracts that were published up to September 2021.</p><p><strong>Results: </strong>The literature search revealed 5719 articles, after deleting duplicates 3616 remained. Finally, 17 studies were included. The pooled prevalence of IBD in MS was 1% (I<sup>2</sup> = 96.3%, <i>P</i> < 0.001). The pooled odds ratio of developing IBD in MS cases was 1.36 (95% CI: 1.1-1.6) (I<sup>2</sup> = 58.3, <i>P</i> = 0.01).</p><p><strong>Conclusions: </strong>The results of this systematic review and meta-analysis show that the pooled prevalence of IBD in MS patients was 1% and the pooled odds ratio of developing IBD in MS cases was 1.36.</p>","PeriodicalId":14342,"journal":{"name":"International Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5d/ea/IJPVM-14-81.PMC10580199.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49677388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Positive Predictive Value of SARS-CoV-2 Spike Protein Antibody Test after COVID-19 Vaccination Policies. 新冠肺炎疫苗接种政策后SARS-CoV-2刺突蛋白抗体检测的阳性预测价值。
IF 2.1 Pub Date : 2023-06-16 eCollection Date: 2023-01-01 DOI: 10.4103/ijpvm.ijpvm_290_21
Pathum Sookaromdee, Viroj Wiwanitkit
{"title":"Positive Predictive Value of SARS-CoV-2 Spike Protein Antibody Test after COVID-19 Vaccination Policies.","authors":"Pathum Sookaromdee,&nbsp;Viroj Wiwanitkit","doi":"10.4103/ijpvm.ijpvm_290_21","DOIUrl":"https://doi.org/10.4103/ijpvm.ijpvm_290_21","url":null,"abstract":"","PeriodicalId":14342,"journal":{"name":"International Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c8/43/IJPVM-14-75.PMC10580214.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49677378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytokine Receptor Allele Frequency, Immunogenicity, and Efficacy of New COVID-19 Vaccine in Different Setting. 新冠肺炎新疫苗在不同环境下的细胞因子受体等位基因频率、免疫原性和疗效。
IF 2.1 Pub Date : 2023-06-16 eCollection Date: 2023-01-01 DOI: 10.4103/ijpvm.ijpvm_37_21
Beuy Joob, Viroj Wiwanitkit
{"title":"Cytokine Receptor Allele Frequency, Immunogenicity, and Efficacy of New COVID-19 Vaccine in Different Setting.","authors":"Beuy Joob,&nbsp;Viroj Wiwanitkit","doi":"10.4103/ijpvm.ijpvm_37_21","DOIUrl":"https://doi.org/10.4103/ijpvm.ijpvm_37_21","url":null,"abstract":"","PeriodicalId":14342,"journal":{"name":"International Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cd/66/IJPVM-14-71.PMC10580194.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49677364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19, Vaccination, Multisystem Inflammatory Syndrome, Aneurysm, Screening and Post Vaccination Death. 新冠肺炎,疫苗接种,多系统炎症综合征,动脉瘤,筛查和疫苗接种后死亡。
IF 2.1 Pub Date : 2023-06-16 eCollection Date: 2023-01-01 DOI: 10.4103/ijpvm.ijpvm_192_21
Beuy Joob, Viroj Wiwanitkit
{"title":"COVID-19, Vaccination, Multisystem Inflammatory Syndrome, Aneurysm, Screening and Post Vaccination Death.","authors":"Beuy Joob,&nbsp;Viroj Wiwanitkit","doi":"10.4103/ijpvm.ijpvm_192_21","DOIUrl":"https://doi.org/10.4103/ijpvm.ijpvm_192_21","url":null,"abstract":"","PeriodicalId":14342,"journal":{"name":"International Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/90/bd/IJPVM-14-74.PMC10580212.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49677363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19, Herd Immunity and Vaccine. 新冠肺炎,群体免疫和疫苗。
IF 2.1 Pub Date : 2023-06-16 eCollection Date: 2023-01-01 DOI: 10.4103/ijpvm.ijpvm_57_21
Sim Sai Tin, Viroj Wiwanitkit
{"title":"COVID-19, Herd Immunity and Vaccine.","authors":"Sim Sai Tin,&nbsp;Viroj Wiwanitkit","doi":"10.4103/ijpvm.ijpvm_57_21","DOIUrl":"https://doi.org/10.4103/ijpvm.ijpvm_57_21","url":null,"abstract":"","PeriodicalId":14342,"journal":{"name":"International Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/90/7d/IJPVM-14-73.PMC10580207.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49677362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccine Hesitancy: A Contemporary Issue for New COVID-19 Vaccination. 疫苗犹豫:新新冠肺炎疫苗接种的当代问题。
IF 2.1 Pub Date : 2023-06-16 eCollection Date: 2023-01-01 DOI: 10.4103/ijpvm.ijpvm_56_21
Pathum Sookaromdee, Viroj Wiwanitkti
{"title":"Vaccine Hesitancy: A Contemporary Issue for New COVID-19 Vaccination.","authors":"Pathum Sookaromdee,&nbsp;Viroj Wiwanitkti","doi":"10.4103/ijpvm.ijpvm_56_21","DOIUrl":"https://doi.org/10.4103/ijpvm.ijpvm_56_21","url":null,"abstract":"","PeriodicalId":14342,"journal":{"name":"International Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/96/f6/IJPVM-14-72.PMC10580183.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49677394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: Is Enough Attention Paid to the Health Effects of Low-Frequency Noise in Today's Society? 在当今社会,低频噪声对健康的影响是否得到了足够的重视?
IF 2.1 Pub Date : 2023-06-16 eCollection Date: 2023-01-01 DOI: 10.4103/2008-7802.378887

[This corrects the article on p. 162 in vol. 13, PMID: 36911004.].

[这更正了第13卷第162页的文章,PMID: 36911004]。
{"title":"Erratum: Is Enough Attention Paid to the Health Effects of Low-Frequency Noise in Today's Society?","authors":"","doi":"10.4103/2008-7802.378887","DOIUrl":"https://doi.org/10.4103/2008-7802.378887","url":null,"abstract":"<p><p>[This corrects the article on p. 162 in vol. 13, PMID: 36911004.].</p>","PeriodicalId":14342,"journal":{"name":"International Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645158/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138459938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined Ursolic Acid and Resistance/Endurance Training Improve Type 3 Diabetes Biomarkers-Related Memory Deficits in Hippocampus of Aged Male Wistar Rats. 熊果酸与阻力/耐力训练相结合可改善老年雄性Wistar大鼠海马体中与3型糖尿病生物标志物相关的记忆缺陷
IF 1.7 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-05-27 eCollection Date: 2023-01-01 DOI: 10.4103/ijpvm.ijpvm_317_21
Neda Ghadiri, Fahimeh Esfarjani, Sayed Mohammad Marandi, Ebrahim Banitalebi, Elham Saghaee

Background: Both aging and diabetes are two well-established risk factors related to type 3 diabetes and memory deficits. Accordingly, diabetes multiplies the effects of aging on cognition impairments once these conditions occur simultaneously.

Methods: In this present experimental study, 56 male Wistar rats with HFD/STZ-induced T2D were randomized into seven groups (n = eight animals per group): (1) sedentary old non-diabetic (C); (2) sedentary HFD/STZ-induced T2D (D); (3) sedentary HFD/STZ-induced T2D plus UA (UA) (DU); (4) endurance-trained HFD/STZ-induced T2D (DE); (5) resistance-trained HFD/STZ-induced T2D (DR); (6) endurance-trained HFD/STZ-induced T2D plus UA (DEU); and (7) resistance-trained STZ-diabetic plus UA (DRU) rats. Two-way ANOVA was applied to measure the training, supplementation, and interaction effect on serum and gene expression outcomes.

Result: The study results established no significant interaction effect between the UA supplementation and the resistance/endurance training with regard to the levels of glucose (P = 0.534), insulin (P = 0.327), brain-derived neurotrophic factor (P = 0.191), and insulin-like growth factor-1 (P = 0.448).

Conclusions: To develop novel practical nutritional strategies involving UA intake, further studies are thus needed to clarify how chronic consumption of UA with/without resistance/endurance training reverses cognition disorder process in old male Wistar rats with HFD/STZ-induced T2D.

背景:衰老和糖尿病是导致 3 型糖尿病和记忆障碍的两个公认的危险因素。因此,一旦同时出现这两种情况,糖尿病会成倍增加衰老对认知障碍的影响:在本实验研究中,56 只雄性 Wistar 大鼠被随机分为 7 组(每组 8 只):(1) 久坐不动的非糖尿病老龄大鼠(C);(2) 久坐不动的 HFD/STZ 诱导的 T2D 大鼠(D);(3) 久坐不动的 HFD/STZ 诱导的 T2D 加 UA(UA)大鼠(DU);(4) 耐力训练的 HFD/STZ 诱导的 T2D 大鼠(DE);(5) 耐力训练的高密度脂蛋白胆固醇/STZ 诱导的 T2D 大鼠(DR);(6) 耐力训练的高密度脂蛋白胆固醇/STZ 诱导的 T2D 加 UA 大鼠(DEU);以及 (7) 耐力训练的 STZ 糖尿病加 UA 大鼠(DRU)。应用双向方差分析来测量训练、补充剂和相互作用对血清和基因表达结果的影响:研究结果表明,补充 UA 和阻力/耐力训练对葡萄糖水平(P = 0.534)、胰岛素水平(P = 0.327)、脑源性神经营养因子水平(P = 0.191)和胰岛素样生长因子-1 水平(P = 0.448)没有明显的交互作用:结论:为了开发新的实用营养策略,需要进一步研究明确长期摄入 UA 和/或不进行阻力/耐力训练如何逆转 HFD/STZ 诱导的 T2D 老年雄性 Wistar 大鼠的认知障碍过程。
{"title":"Combined Ursolic Acid and Resistance/Endurance Training Improve Type 3 Diabetes Biomarkers-Related Memory Deficits in Hippocampus of Aged Male Wistar Rats.","authors":"Neda Ghadiri, Fahimeh Esfarjani, Sayed Mohammad Marandi, Ebrahim Banitalebi, Elham Saghaee","doi":"10.4103/ijpvm.ijpvm_317_21","DOIUrl":"10.4103/ijpvm.ijpvm_317_21","url":null,"abstract":"<p><strong>Background: </strong>Both aging and diabetes are two well-established risk factors related to type 3 diabetes and memory deficits. Accordingly, diabetes multiplies the effects of aging on cognition impairments once these conditions occur simultaneously.</p><p><strong>Methods: </strong>In this present experimental study, 56 male Wistar rats with HFD/STZ-induced T2D were randomized into seven groups (<i>n</i> = eight animals per group): (1) sedentary old non-diabetic (C); (2) sedentary HFD/STZ-induced T2D (D); (3) sedentary HFD/STZ-induced T2D plus UA (UA) (DU); (4) endurance-trained HFD/STZ-induced T2D (DE); (5) resistance-trained HFD/STZ-induced T2D (DR); (6) endurance-trained HFD/STZ-induced T2D plus UA (DEU); and (7) resistance-trained STZ-diabetic plus UA (DRU) rats. Two-way ANOVA was applied to measure the training, supplementation, and interaction effect on serum and gene expression outcomes.</p><p><strong>Result: </strong>The study results established no significant interaction effect between the UA supplementation and the resistance/endurance training with regard to the levels of glucose (<i>P</i> = 0.534), insulin (<i>P</i> = 0.327), brain-derived neurotrophic factor (<i>P</i> = 0.191), and insulin-like growth factor-1 (<i>P</i> = 0.448).</p><p><strong>Conclusions: </strong>To develop novel practical nutritional strategies involving UA intake, further studies are thus needed to clarify how chronic consumption of UA with/without resistance/endurance training reverses cognition disorder process in old male Wistar rats with HFD/STZ-induced T2D.</p>","PeriodicalId":14342,"journal":{"name":"International Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fd/02/IJPVM-14-65.PMC10284247.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9711852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Preventive Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1